Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study

References

• Lok AS. Navigating the maze of hepatitis B treatments. Gastroenterology 2007;132:1586–94.
   PubMed Web of Science ®Google Scholar
• Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology 2006;43:1385–91.
   PubMed Web of Science ®Google Scholar
• Yeon JE, Yoo W, Hong SP, Chang YJ, Yu SK, Kim JH, Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil. Gut 2006;55:1488–95.
   PubMed Web of Science ®Google Scholar
• Fung SK, Chae HB, Fontana RJ, Conjeevaram H, Marrero J, Oberhelman K, Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol 2006;44:283–90.
   PubMed Web of Science ®Google Scholar
• Rapti I, Dimou E, Mitsoula P, Hadziyannis SJ. Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology 2007;45:307–13.
   PubMed Web of Science ®Google Scholar
• Lampertico P, Vigano M, Manenti E, Iavarone M, Sablon E, Colombo M. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology 2007;133:1445–51.
   PubMed Web of Science ®Google Scholar
• Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology 2009;49:1503–14.
   PubMed Web of Science ®Google Scholar
• Sherman M, Yurdaydin C, Sollano J, Silva M, Liaw YF, Cianciara J, Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology 2006;130:2039–49.
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The L. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167–85.
   PubMed Web of Science ®Google Scholar
• Heo NY, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir. J Hepatol 2010;53:449–54.
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim HJ, Park JY, Lee CK, Kim do Y, Kim JK, Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir. Antivir Ther 2009;14:705–12.
   PubMed Web of Science ®Google Scholar
• Ryu HJ, Lee JM, Ahn SH, Kim do Y, Lee MH, Han KH, Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B. J Med Virol 2010;82:1835–42.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy. J Gastroenterol Hepatol 2010;25:1374–80.
   PubMed Web of Science ®Google Scholar
• Chung GE, Kim W, Lee KL, Hwang SY, Lee JH, Kim HY, Add-on adefovir is superior to a switch to entecavir as rescue therapy for lamivudine-resistant chronic hepatitis B. Dig Dis Sci 2011;56:2130–6.
   PubMed Web of Science ®Google Scholar
• Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother 2004;48:3498–507.
   PubMed Web of Science ®Google Scholar
• Villet S, Ollivet A, Pichoud C, Barraud L, Villeneuve JP, Trepo C, Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient. J Hepatol 2007;46:531–8.
   PubMed Web of Science ®Google Scholar
• Baldick CJ, Tenney DJ, Mazzucco CE, Eggers BJ, Rose RE, Pokornowski KA, Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance. Hepatology 2008;47:1473–82.
   PubMed Web of Science ®Google Scholar
• Vassiliadis TG, Giouleme O, Koumerkeridis G, Koumaras H, Tziomalos K, Patsiaoura K, Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study. J Gastroenterol Hepatol 2010;25:54–60.
   PubMed Web of Science ®Google Scholar
• van Bommel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology 2010;51:73–80.
   PubMed Web of Science ®Google Scholar
• Ha M, Zhang G, Diao S, Lin M, Wu J, Sun L, Rescue therapy for lamivudine-resistant chronic hepatitis b: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy. Intern Med 2012;51:1509–15.
   PubMed Web of Science ®Google Scholar
• Lim YS, Lee JY, Lee D, Shim JH, Lee HC, Lee YS, Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir. Antimicrob Agents Chemother 2012;56:2941–7.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.
   PubMed Web of Science ®Google Scholar
• Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678–86.
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661–2.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Song BC. Distribution of hepatitis B virus genotypes according to the clinical outcomes in patients with chronic hepatitis B virus infection in Jeju island. Korean J Gastroenterol 2003;42:496–501.
   PubMedGoogle Scholar
• Song BC, Cui XJ, Kim H. Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection. Intervirology 2005;48:133–7.
   PubMed Web of Science ®Google Scholar
• Kim H, Jee YM, Song BC, Shin JW, Yang SH, Mun HS, Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 2007;50:52–7.
   PubMed Web of Science ®Google Scholar